NewswireToday - /newswire/ -
Leytonstone, London, United Kingdom, 2010/11/03 - The NWCCA is the award winning collaborative procurement agency for NHS Trusts across the North West of England and over the last five years has helped achieve savings of more than £110 million.
G2 Speech - the leading provider of medical speech solutions has been appointed as a preferred supplier for digital dictation and speech recognition solutions to the North West Collaborative Commercial Agency (NWCCA) framework.
The NWCCA is the award winning collaborative procurement agency for NHS Trusts across the North West of England and over the last five years has helped achieve savings of more than £110 million by embedding commercial best practice and ensuring value for money procurement services.
Being appointed as a preferred supplier means that G2 Speech is in a prime position to enable the NWCCA’s 53 NHS member Trusts improve efficiency and make impressive cost reductions, both of which will contribute to improving patient care.
Henry Gallagher, MD of G2 Speech UK said: "Hundreds of companies applied to join this framework, and it is a mark of the quality of the digital dictation and speech recognition solutions that G2 Speech are supplying to NHS Trusts that we are one of the select few suppliers appointed to the framework. G2 Speech provides NHS Trusts with speech solutions from single GPs right up to trust wide implementations.
In Holland over 95% of hospitals already use a G2 Speech solution and NHS organisations in the UK are quickly realising why solutions like MediSpeech are the best choice for them too."
About the framework, Andy Brown, Interim Director of Strategic Sourcing at the NWCCA commented: “We are delighted to launch this digital dictation framework which, by following a rigorous procurement process, will provide Trusts with easy access to a range of quality suppliers all of whom have proven they can deliver the type of digital dictation solutions required at competitive rates. It is clear that through the innovative solutions these suppliers provide there are significant savings to be made in this area which can be reinvested to further enhance the quality of care provided to patients.”
About G2 Speech
G2 Speech (g2speech.com) is the market leader in speech recognition and digital dictation solutions for hospitals and other health care organisations. Using efficient and highly accurate digital technologies created specifically for the medical environment, G2 Speech solutions improve workflow efficiency and deliver significant reductions in cost.
G2 Speech works with more than 95% of hospitals in the Netherlands and the Company’s implementation, training and support services are expanding rapidly across the UK and Belgium.
The impressive accuracy rates (up to 98%) achieved with speech recognition software from G2 Speech mean that health care professionals are now recording and distributing their consultation notes and other information almost instantly.
These medical speech recognition solutions are delivering such impressive returns on investment for NHS trusts, GP surgeries and other health care organisations that G2 Speech would be glad to arrange for you to talk with customers who have implemented speech recognition across their departments and trusts.
More information is available online or call 0208 539 6541
About the NWCCA
The NWCCA (nwcca.nhs.uk) is an NHS organisation, established by the NHS, for the NHS and drives improved procurement and commercial efficiencies across the North West health economy.
We do this by embedding commercial best practice and ensuring value for money procurement by offering a broad range of enhanced and optional commercial and contracting services to our 53 member Trusts who own and fund the organisation.
Blending public sector values with private sector ethos the NWCCA maximises the NHS’s enormous purchasing power, not just to save money, but also to improve quality, patient safety and reduce inefficiencies.
Over the past five years, the NWCCA has helped Trusts achieve savings of more than £110 million which have been reinvested to further enhance the quality of patient care.